title: Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time.
abstract: In lung transplant patients undergoing immunosuppression, more than one human cytomegalovirus (HCMV) genotype may emerge during follow-up, and this could be critical for the outcome of HCMV infection. Up to now, many cases of infection with multiple HCMV genotypes were probably overlooked due to the limitations of the current genotyping approaches. We have now analyzed mixed-genotype infections in 17 clinical samples from 9 lung transplant patients using the highly sensitive ultradeep-pyrosequencing (UDPS) technology. UDPS genotyping was performed at three variable HCMV genes, coding for glycoprotein N (gN), glycoprotein O (gO), and UL139. Simultaneous analysis of a mean of 10,430 sequence reads per amplicon allowed the relative amounts of distinct genotypes in the samples to be determined down to 0.1% to 1% abundance. Complex mixtures of up to six different HCMV genotypes per sample were observed. In all samples, no more than two major genotypes accounted for at least 88% of the HCMV DNA load, and these were often accompanied by up to four low-abundance genotypes at frequencies of 0.1% to 8.6%. No evidence for the emergence of new genotypes or sequence changes over time was observed. However, analysis of different samples withdrawn from the same patients at different time points revealed that the relative levels of replication of the individual HCMV genotypes changed within a mixed-genotype population upon reemergence of the virus. Our data show for the first time that, similar to what has been hypothesized for the murine model, HCMV reactivation in humans seems to occur stochastically.
authors.affiliation: Medical University of Vienna, Department of Virology, Kinderspitalgasse 15, A-1095 Vienna, Austria.
authors.forename: Irene
authors.initials: I
authors.lastname: Görzer
authors.forename: Christian
authors.initials: C
authors.lastname: Guelly
authors.forename: Slave
authors.initials: S
authors.lastname: Trajanoski
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Puchhammer-Stöckl
mesh_terms: D000818:Animals; D001483:Base Sequence; D003587:Cytomegalovirus / Q000145:classification / Q000235:genetics*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000821:virology*; D004279:DNA, Viral / Q000235:genetics; D005838:Genotype; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects; D051379:Mice; D008969:Molecular Sequence Data; D010802:Phylogeny; D016415:Sequence Alignment; D017422:Sequence Analysis, DNA / Q000379:methods; D013997:Time Factors; D019562:Viral Load
chemical_list: D004279:DNA, Viral
references.citation: Virology. 2009 Aug 1;390(2):330-7
references.pmid: 19524994
references.citation: J Gen Virol. 2003 Mar;84(Pt 3):647-655
references.pmid: 12604817
references.citation: Clin Infect Dis. 2008 Mar 15;46(6):831-9
references.pmid: 18269330
references.citation: Microbes Infect. 2008 Oct;10(12-13):1363-9
references.pmid: 18761415
references.citation: Clin Infect Dis. 2009 Oct 15;49(8):1160-6
references.pmid: 19751151
references.citation: J Virol. 1999 Oct;73(10):8612-22
references.pmid: 10482614
references.citation: Mol Biol Evol. 2007 Aug;24(8):1596-9
references.pmid: 17488738
references.citation: J Med Virol. 2008 Aug;80(8):1405-14
references.pmid: 18551598
references.citation: J Med Virol. 2005 Jan;75(1):42-6
references.pmid: 15543586
references.citation: J Gen Virol. 2001 Nov;82(Pt 11):2777-2784
references.pmid: 11602789
references.citation: Lancet. 1998 Oct 17;352(9136):1280-1
references.pmid: 9788461
references.citation: J Clin Microbiol. 2008 Dec;46(12):4004-10
references.pmid: 18971365
references.citation: Virology. 2008 Aug 15;378(1):86-96
references.pmid: 18556037
references.citation: J Virol. 2002 Nov;76(21):10841-8
references.pmid: 12368327
references.citation: J Exp Med. 1994 Jan 1;179(1):185-93
references.pmid: 8270864
references.citation: J Virol. 2005 Aug;79(15):9492-502
references.pmid: 16014912
references.citation: Clin Microbiol Rev. 1997 Jan;10(1):86-124
references.pmid: 8993860
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14223-8
references.pmid: 14623981
references.citation: J Gen Virol. 2005 Nov;86(Pt 11):2949-2954
references.pmid: 16227215
references.citation: Genome Res. 2007 Aug;17(8):1195-201
references.pmid: 17600086
references.citation: Am J Transplant. 2009 Nov;9(11):2453-8
references.pmid: 19843027
references.citation: J Clin Microbiol. 2003 Jul;41(7):2872-7
references.pmid: 12843015
references.citation: J Virol. 2003 Feb;77(3):1840-7
references.pmid: 12525618
references.citation: Rev Med Virol. 2004 Nov-Dec;14(6):383-410
references.pmid: 15386592
references.citation: N Engl J Med. 2001 May 3;344(18):1366-71
references.pmid: 11333993
references.citation: Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):286-95
references.pmid: 19682613
references.citation: J Gen Virol. 2004 May;85(Pt 5):1301-1312
references.pmid: 15105547
references.citation: Am J Transplant. 2004 Aug;4(8):1219-26
references.pmid: 15268722
references.citation: Curr Top Microbiol Immunol. 2008;325:315-31
references.pmid: 18637514
references.citation: J Virol Methods. 1989 Dec;26(3):345-9
references.pmid: 2559924
references.citation: J Virol. 2005 Aug;79(16):10330-8
references.pmid: 16051825
references.citation: Transplantation. 2006 Jan 27;81(2):187-94
references.pmid: 16436961
references.citation: Genome Biol. 2007;8(7):R143
references.pmid: 17659080
references.citation: Curr Top Microbiol Immunol. 2008;325:297-313
references.pmid: 18637513
references.citation: J Gen Virol. 2009 Aug;90(Pt 8):1951-1961
references.pmid: 19420160
references.citation: Lancet Infect Dis. 2004 Dec;4(12):725-38
references.pmid: 15567122
references.citation: J Clin Virol. 2006 Aug;36(4):239-48
references.pmid: 16697698
references.citation: J Med Virol. 2008 Sep;80(9):1615-23
references.pmid: 18649324
references.citation: J Virol. 2004 Sep;78(18):10023-33
references.pmid: 15331735
references.citation: J Gen Virol. 2010 Mar;91(Pt 3):605-15
references.pmid: 19906940
references.citation: J Virol. 2005 Jan;79(1):326-40
references.pmid: 15596827
references.citation: Curr Opin Immunol. 2007 Oct;19(5):577-82
references.pmid: 17716883
references.citation: J Infect Dis. 2003 Aug 15;188(4):581-4
references.pmid: 12898447
references.citation: J Virol. 1994 Mar;68(3):1597-604
references.pmid: 8107221
references.citation: J Virol. 2009 Oct;83(19):10293-8
references.pmid: 19605491
references.citation: Virus Res. 2006 Apr;117(1):90-104
references.pmid: 16490275
references.citation: Transpl Immunol. 2009 May;21(1):1-9
references.pmid: 19162183
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5
references.pmid: 15738399
references.citation: Virol J. 2006 Jan 12;3:4
references.pmid: 16409621
references.citation: J Gen Virol. 2010 Mar;91(Pt 3):599-604
references.pmid: 19906945
references.citation: Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
references.pmid: 9396791
references.citation: Virology. 2004 Jan 20;318(2):582-97
references.pmid: 14972526
references.citation: J Clin Microbiol. 2008 Mar;46(3):882-6
references.pmid: 18216215